OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript March 5, 2026 OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.51, expectations were $0.23. Operator: Good ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果